Search Results 451-460 of 17000 for monoclonal antibody
Monoclonal antibodies, such as durvalumab and tremelimumab, may interfere with the ability of tumor cells to grow and spread. Radiation therapy uses high ...
Monoclonal antibodies, such as nivolumab and brentuximab vedotin, may interfere with the ability of cancer cells to grow and spread. Participation ...
These fully humanized, monoclonal antibodies block negative regulatory receptors (for example, CTLA-4 or PD-1) on T cells, resulting in a de-repression or ...
Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...
Antibody-drug conjugates, such as lorvotuzumab mertansine, are ... Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways.
When bone marrow produces an unusual protein in the blood, it can sometimes lead to certain types of blood cancer.
The neutralizing antibody test provides semi-quantitative detection of total neutralizing antibodies against the SARS-CoV-2 spike glycoprotein in human serum.
Monoclonal antibodies, such as rituximab, can block cancer growth in difference ways. Some block the ability of cancer cells to grow and spread. Others find ...
... monoclonal antibody. That randomization will occur when a participant has experienced post-traumatic headache for 35 to 56 days. Dr. Schwedt notes that ...
She is a laboratory director for the Protein Immunology, Antibody ... Her research interests span the areas of complement, monoclonal antibody therapies, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.